Dr. Mittalhenkle joins the staff upon graduating from the Transplant Fellowship in the Division of Nephrology & Hypertension.

Degrees:

B.S. – Stanford University, 1990
M.D. – University of California, Los Angeles, 1997
M.P.H. – University of Washington, 2004

Residency:

Internal Medicine – UCLA Medical Center, 1997-2000

Fellowship:

Nephrology – University of Washington, 2001-2004
Transplant Medicine — Oregon Health & Science University 2004-2005

Research Interest:

Renal Transplantation, Epidemiology of acute renal failure, Bone disease in renal patients.

Clinical Interest:

Renal Transplantation

Representative Publications:

• Anuja Mittalhenkle, Daniel Gillen and Catherine Stehman-Breen. Increased risk of mortality associated with hip fracture in the dialysis population. American Journal of Kidney Diseases, 2004 (in press)
• Anuja Mittalhenkle, Catherine Stehman-Breen, Michael Shlipak, Linda Fried, Ronit Katz, Bessie Young, Stephen Seliger, Daniel Gillen, Anne Newman, Bruce Psaty, David Siscovick. Cardiovascular risk factors for acute renal failure in the elderly.  Accepted for a poster presentation at the American Society of Nephrology, Oct 2004.
• Anuja Mittalhenkle, Swee May Tang, Cathy W. Critchlow, Stephen E. Hawes. Pregnancy and infant outcomes in women with renal disease. Presented as a poster at the Washington state Joint Conference on Health. Oct. 2003.
• Paul H Brion, Anuja Mittal-Henkle, Kenneth Kalunian.  Autoimmune skin rashes associated with Etanercept for Rheumatoid Arthritis. (Letter) Annals of Internal Medicine 1999 Oct 131(8): 63
• Schiller G, Lee M, Miller T, Lill M, Mittal-Henkle A, Paquette R, Sawyers C, Territo M Transplantation of autologous peripheral blood progenitor cells procured after high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia in first remission. Leukemia, 1997 Sep 11(9): 1533-9.
• G. Schiller, R. Vescio, A. Mittal-Henkle, L. Rosen, R. Beesmeyer, J. Berenson.  A phase I-II study of infusional idarubicin, cyclophosphamide, and etoposide for the treatment of resistant multiple myeloma.  (Abstr) Blood 1995; 86(suppl. I): 842A.  Presented as a poster at the American Society of Hematology, 37th Annual meeting, Dec. 1995.